1249 Combination of platinum standard first front line chemotherapy and anti-idiotype 1E10/aluminum vaccine in patients with advanced non- small- cell lung cancer (NSCLC)

A.Macias; D.Toledo; E.Santiesteban; F.Aguirre; X.Popa; A.Vazquez; Z.Mazorra; T.Crombet; R.Perez

首页> 外文期刊>European Journal of Cancer Supplements >1249 Combination of platinum standard first front line chemotherapy and anti-idiotype 1E10/aluminum vaccine in patients with advanced non- small- cell lung cancer (NSCLC)

【24h】

1249 Combination of platinum standard first front line chemotherapy and anti-idiotype 1E10/aluminum vaccine in patients with advanced non- small- cell lung cancer (NSCLC)

机译：1249晚期非小细胞肺癌（NSCLC）患者联合铂标准一线化疗和抗独特型1E10 /铝疫苗

获取原文

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《European Journal of Cancer Supplements》 |2009年第2期|共1页
作者
A.Macias; D.Toledo; E.Santiesteban; F.Aguirre; X.Popa; A.Vazquez; Z.Mazorra; T.Crombet; R.Perez;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. 1249 Combination of platinum standard first front line chemotherapy and anti-idiotype 1E10/aluminum vaccine in patients with advanced non- small- cell lung cancer (NSCLC) [J] . A.Macias, D.Toledo, E.Santiesteban, European Journal of Cancer Supplements . 2009,第2期

机译：1249晚期非小细胞肺癌（NSCLC）患者联合铂标准一线化疗和抗独特型1E10 /铝疫苗
2. AvaALL: Open-Label Randomized Phase 1Mb Trial Evaluating the Efficacy and Safety of Standard of Care With or Without Continuous Bevacizumab (BV) Treatment Beyond Disease Progression in Patients (pts) With Advanced Nonsquamous Non-Small Cell Lung Cancer (NSCLC) After First-Line (1L) Treatment With BV Plus Platinum-Doublet Chemotherapy (CT) [J] . Clinical advances in hematology & oncology: H&O . 2012,第Suppla11期

机译：AvaALL：开放标签随机1Mb临床试验，评估在初次手术后晚期非鳞状非小细胞肺癌（NSCLC）患者病情进展之外，是否进行持续贝伐单抗（BV）治疗的标准治疗的有效性和安全性BV加上铂金双线化疗（CT）的线（1L）治疗
3. Nivolumab (Anti-PD-1; BMS-936558, ONO-4538) in Combination With Platinum-Based Doublet Chemotherapy (PT-DC) in Advanced Non-Small Cell Lung Cancer (NSCLC) [J] . Antonia S. J., Brahmer J. R., Gettinger S., International Journal of Radiation Oncology, Biology, Physics . 2014,第5Suppla期

机译：Nivolumab（Anti-PD-1; BMS-936558，ONO-4538）与晚期非小细胞肺癌（NSCLC）的铂基双线化疗（PT-DC）联合使用
4. Pemetrexed versus docetaxel single agent chemotherapy in chemotherapy-naive elderly patients with advanced non-small cell lung cancer [C] . Hua Xin, Zhenguo Han, Haibo Huang 2011 International Conference on Human Health and Biomedical Engineering . 2011

机译：培美曲塞与多西他赛单药化疗在未接受化疗的老年晚期非小细胞肺癌患者中的作用
5. Predictors of changes in health-related quality of life during chemotherapy in an advanced non-small cell lung cancer patient population [D] . Shallwani, Shirin Mehdi 2010

机译：非小细胞肺癌晚期患者化疗期间健康相关生活质量变化的预测因子
6. Metronomic Cyclophosphamide and Methotrexate Chemotherapy Combined with 1E10 Anti-Idiotype Vaccine in Metastatic Breast Cancer [O] . Jorge L. Soriano, Noyde Batista, Eduardo Santiesteban, 2011

机译：节律性环磷酰胺和甲氨蝶呤化疗联合1E10抗独特型疫苗治疗转移性乳腺癌
7. PD3-2-7: Implications of tumour cavitation on response assessment in trials of Vascular Endothelial Growth Factor Receptor (VEGFR) Inhibitors in combination with platinum-based chemotherapy for advanced non-small cell lung cancer (NSCLC): An analysis of trials conducted by the National Cancer Institute of Canada Clinical Trials Group (NCIC CTG). [O] . Laurie Scott A., Crabb Simon, Arnold Andrew, 2007

机译：PD3-2-7：在晚期非小细胞肺癌（NSCLC）的血管内皮生长因子受体（VEGFR）抑制剂联合铂类化疗的试验中，肿瘤空化对反应评估的意义：加拿大国家癌症研究所临床试验小组（NCIC CTG）。

1249 Combination of platinum standard first front line chemotherapy and anti-idiotype 1E10/aluminum vaccine in patients with advanced non- small- cell lung cancer (NSCLC)

著录项

引文网络

相似文献

相关主题

期刊订阅